Patent ID: 11878995
Assignee: SAGE THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 0:
1. A method of treating a CNS-related condition selected from a group consisting of an adjustment disorder, anxiety disorder, dissociative disorder, eating disorder, mood disorder, schizophrenia or other psychotic disorder, sleep disorder, substance-related disorder, personality disorder, autism spectrum disorders, multiple sclerosis, pain, seizure disorder, stroke, traumatic brain injury, movement disorder, vision impairment, hearing loss, or tinnitus, wherein the method comprises administering to a subject in need thereof an effective amount of a compound of Formula (I):, , or a pharmaceutically acceptable salt thereof, wherein:
R1 is hydrogen or deuterium;
each of R2 and R3 is independently deuterium or —C1-6 alkyl;
R4 is hydrogen or deuterium;
R5 is absent, hydrogen, or deuterium;
n is 1 or 2;
 represents a single or double bond, wherein when one  is a double bond, the other  is a single bond and R5 is absent; and
at least one of R1, R2, R3, R4, or R5 is deuterium.